1. Home
  2. EGY vs CRVS Comparison

EGY vs CRVS Comparison

Compare EGY & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

HOLD

Current Price

$5.36

Market Cap

652.7M

Sector

Energy

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$12.72

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EGY
CRVS
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
652.7M
1.2B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
EGY
CRVS
Price
$5.36
$12.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$7.30
$30.17
AVG Volume (30 Days)
1.2M
1.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
3.75%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
$359,272,000.00
N/A
Revenue This Year
$8.78
N/A
Revenue Next Year
$29.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$3.55
52 Week High
$6.72
$26.95

Technical Indicators

Market Signals
Indicator
EGY
CRVS
Relative Strength Index (RSI) 34.80 40.84
Support Level $5.01 $11.42
Resistance Level $5.38 $19.21
Average True Range (ATR) 0.20 1.06
MACD -0.09 -0.17
Stochastic Oscillator 5.20 24.03

Price Performance

Historical Comparison
EGY
CRVS

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: